Take the Quiz
Guide · Updated October 16, 2026

Semaglutide Insurance Coverage

Brand Wegovy is covered by many commercial plans for BMI documentation; Medicare Part D expanded for CV indication in 2024. Compounded is generally cash-pay (HSA/FSA accepted).

EducationalUpdated October 16, 2026
SS
Editorial team
Dr. Sam Saberian · Lead Medical Researcher
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated October 16, 2026

Overview

Brand Wegovy is covered by many commercial plans for BMI documentation; Medicare Part D expanded for CV indication in 2024. Compounded is generally cash-pay (HSA/FSA accepted).

Related guides

Questions readers ask

Does Medicare cover Wegovy in 2026?

Part D coverage expanded in 2024 for cardiovascular risk reduction. In addition, the Medicare GLP-1 Bridge runs July 1, 2026 to December 31, 2027 with a $50 copay for eligible Part D members on Wegovy, Foundayo or Zepbound KwikPen, subject to prior authorization and BMI-based criteria.

Is Ozempic easier to get covered than Wegovy?

Ozempic is widely covered for type 2 diabetes, while commercial coverage for Wegovy usually depends on BMI documentation. Formularies vary, so check your own plan’s criteria and whether prior authorization is required.

Can I use insurance for compounded semaglutide?

Generally no. Compounded semaglutide is cash-pay, although HSA and FSA funds are accepted. NexLife, for example, lists $119 a month on a 12-month plan charged monthly or $139 month to month (read October 14, 2026), with no insurance billing.

What does Wegovy cost if my plan will not cover it?

NovoCare self-pay lists the Wegovy pill at $149, $199 or $299 a month by dose and the Wegovy pen at $349 a month, with new patients paying $199 for the first two fills through December 31, 2026 (read October 14, 2026).

Primary sources

  1. FDA: Concerns with unapproved GLP-1 drugs used for weight loss (current as of October 1, 2026)
  2. FDA: Policies for compounders as GLP-1 supply stabilizes (updated April 1, 2026)
  3. FDA: Compounding and the FDA — questions and answers
  4. FDA: Registered outsourcing facilities (503B)
  5. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med 2021
  6. Wegovy (semaglutide) prescribing information, Novo Nordisk